MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA ALTO; MAIN BODY

Model Number	TV-AB2080-N
Medical Device Problem Codes	Difficult to Advance (2920); Insufficient Device Problem Information (3190)
Health Effect - Clinical Code	Failure of Implant (1924)
Date of Event	06/10/2021
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
Event or Problem Description
The patient was implanted with the alto stent graft system to treat an abdominal aortic aneurysm (aaa).During this initial procedure, the physician had difficultly when advancing and deploying the integrated balloon causing the main body (stent graft) to move upward encroached on the lowest right renal artery.The physician decided to use a non-endologix (coda) balloon to pull the stent graft back down to its original position and was able to move it down a couple millimeters.There was an intraoperative type 1a endoleak at the end of the case.After further ballooning the endoleak looked improved and both renal arteries were filling.The patient is doing well and was discharged.
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows that the type 1a endoleak at the procedure completion is confirmed; however the one month post ct study shows the endoleak has resolved.This is moderately consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest a type 2 endoleak from the inferior mesentery artery.Procedure related harms, device, user, procedure or anatomy relatedness of this complaint could not be determined with the medical records available for review.Type 2endoleaks are anatomy related events and are not caused or contributed by the device.The final patient status was reported as doing well.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: h6: device code: remove code 3190.H6: result code: remove code 3233.H6: conclusion code: remove code 11.
Event or Problem Description
The patient was implanted with the alto stent graft system to treat an abdominal aortic aneurysm (aaa).During this initial procedure, the physician had difficultly when advancing and deploying the integrated balloon causing the main body (stent graft) to move upward encroached on the lowest right renal artery.The physician decided to use a non-endologix (coda) balloon to pull the stent graft back down to its original position and was able to move it down a couple millimeters.There was an intraoperative type 1a endoleak at the end of the case.After further ballooning the endoleak looked improved and both renal arteries were filling.The patient is doing well and was discharged.Additional information: upon the internal review of the one month post computed tomography (ct) study the type 1a endoleak was found to have resolved and there was a type 2 endoleak from the inferior mesentery artery.

• Brand Name: ALTO
• Common Device Name: MAIN BODY
• Manufacturer (Section D): ENDOLOGIX SANTA ROSA; 3910 brickway blvd; santa rosa CA 95403
• MDR Report Key: 12059707
• Report Number: 3008011247-2021-00062
• Device Sequence Number: 3502696
• Product Code: MIH
• UDI-Device Identifier: 00850007370381
• UDI-Public: (01)00850007370381(17)240428(10)FS04272123
• Combination Product (Y/N): N
• Initial Reporter State: PA
• Initial Reporter Country: US
• PMA/510(K) Number: P120006
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2021
• Reporter Type: Manufacturer
• Report Source: company representative,health
• Initial Reporter Occupation: Physician
• Remedial Action: Other
• Type of Report: Initial,Followup
• Report Date (Section B): 06/10/2021

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 04/28/2024
• Device Model Number: TV-AB2080-N
• Device Lot Number: FS042721-23
• Was Device Available for Evaluation?: No
• Initial Date Received by Manufacturer: 06/10/2021
• Supplement Date Received by Manufacturer: 07/23/2021
• Initial Report FDA Received Date: 06/24/2021
• Supplement Report FDA Received Date: 08/12/2021
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: OVATION IX ILIAC LIMB, LOT # FS072420-15; OVATION IX ILIAC LIMB, LOT # FS081820-07; OVATION PRIME FILL POLYMER, LOT # FF010821-01; OVATION IX ILIAC LIMB, LOT # FS072420-15; OVATION IX ILIAC LIMB, LOT # FS081820-07; OVATION PRIME FILL POLYMER, LOT # FF010821-01
• Outcome Attributed to Adverse Event: Other
• Patient Age: 77 YR